Ampersand Biosciences Receives SBIR Grant 2024

Ampersand Biosciences and Trudeau Institute have been awarded a $1,084,824 Phase II Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID).

Species: Ferret
Focus: Validation of Monoclonal Antibodies to Study Respiratory Infections in the Ferret